CYduct Diagnostics, Inc.
CYDX
$0.498
$0.012.05%
OTC PK
| 03/31/2012 | 12/31/2011 | ||||
|---|---|---|---|---|---|
| Revenue | 32.83% | -12.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.83% | -12.71% | |||
| Cost of Revenue | 64.41% | -12.94% | |||
| Gross Profit | 18.97% | -12.76% | |||
| SG&A Expenses | 42.15% | -66.88% | |||
| Depreciation & Amortization | -- | -100.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 46.51% | -62.56% | |||
| Operating Income | -71.11% | 81.52% | |||
| Income Before Tax | 11.20% | 59.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.20% | 59.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.20% | 59.54% | |||
| EBIT | -71.11% | 81.52% | |||
| EBITDA | -63.70% | 81.35% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||